Michal Fila MD, PhD, is a neurologist and neurophysiologist at the Department of Developmental Neurology & Epileptology, Polish Mother Memorial Hospital Research Institute in Lodz, Poland, and the Department of Neurology with Clinical Neurophysiology Lab & Stroke Unit at the Regional County Hospital in Sieradz, Poland. He graduated with a degree in medicine in 2002 and earned his PhD in 2011 from the Faculty of Medicine at the Medical University of Lodz. He completed a research internship at La Sapienza University of Rome in the Department of Neurology, Neuromuscular Diseases Unit, Rome, Italy. He is a member of Editorial Board in The Journal of Headache and Pain and serves as a guest editor for the Collection „The Epigenome and Transriptome in Headache Disorders” in this above periodic and as a guest editor for the International Journal of Molecular Sciences, also. He is a member of the European Headache Federation, International Headache Society, American Headache Society, Canadian Headache Society and Polish Headache Society. His clinical focus is on migraine, which includes BoNTA therapy and migraine chronification. His research interests center on the molecular aspects of migraine pathogenesis, exploring neural plasticity's role in pain chronification, epigenetic regulation of gene expression related to acquiring the migraine phenotype, and the significance of tryptophan metabolism, mitochondrial impairment, disrupted autophagy, DNA damage response, and mRNA trafficking in migraine pathogenesis.
Enter your email to receive alerts when new articles and issues are published.
Brain Conflux is open access. All content is freely available to read, download and share immediately upon publication.
Brain Conflux is licensed under a Creative Commons Attribution 4.0 International License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Submission of a manuscript to the Brain Conflux journal directly implies that all the authors have read and agreed to the journal's guidelines. The content present in the manuscript after publication will be freely available to all the potential readers over the Internet.
The content provided by the authors in the manuscript should at no point of time breach the Copyrights or rights of a third party. The manuscript submitted should not be published or submitted for consideration in any other journal. Manuscripts with plagiarized content will not be considered for the peer-review process.
DOI is registered through Crossref to ensure that each content has a unique identifier and supports citation statistics and long-term content preservation.